interferon beta-1b
Sign in to saveAlso known as IFN beta 1b, Betaseron, Interferon beta precursor, IFN-beta, Fibroblast interferon
pharmaceutical drug
Chemical data
Drug data · ChEMBL
- Max clinical phase
- Approved
- Molecule type
- Protein
- First approval
- 1993
- Admin. routes
- parenteral
- Indications
- relapsing-remitting multiple sclerosis, cardiomyopathy, HIV infection, Middle East respiratory syndrome
via ChEMBL · EBI
Research
1,807 papers- Interferon beta-1b.Lancet (London, England) · 1994
- Interferon-β-1b: a review of its use in multiple sclerosis.CNS drugs · 2011
- Interferon beta-1B--hope or hype?Drug and therapeutics bulletin · 1996
- Interferon-beta-1b: in newly emerging multiple sclerosis.CNS drugs · 2008
- Interferon-beta-1b: a review of its use in relapsing-remitting and secondary progressive multiple sclerosis.CNS drugs · 2004
via PubMed
Wikidata facts
- Has use
- medication
Show 3 more facts
- route of administration
- subcutaneous injection
- subject has role
- immunologic adjuvant
- has characteristic
- biopharmaceutical
via Wikidata · CC0
Available in 15 languages
- Español
- Русский
- Português
- Italiano
- العربية
- Czech
- Hebrew
- Macedonian
- Nederlands
- Polski
- Serbian
- Serbian (Latin)
- Tiếng Việt
- فارسی
via Wikidata sitelinks · CC0